Table 1. List of Glide docking scores and MM-PBSA-WSAS binding free energies for potential inhibitors binding to SARS-Cov-2 main protease (in kcal/mol).
Compound Name | Docking Score | ΔEEEL | ΔEVDW | ΔGPB | ΔGSA | TΔS | ΔGbind |
---|---|---|---|---|---|---|---|
Co-crystal ligand covalently bonds to sulfur of CYS145 | - | −75.1 ± 0.3 | −82.0 ± 0.4 | 84.0 ± 0.2 | −6.5 ± 0.0 | −29.8 ± 0.1 | −38.8 ± 0.6 |
Co-crystal ligand (no covalent bond formed) | −9.4 | −52.3 ± 0.3 | −26.9 ± 0.3 | 56.3 ± 0.2 | −4.8 ± 0.0 | −24.1 ± 0.1 | −3.6 ± 0.4 |
Neutral Approved Drugs | |||||||
DB08889 | −8.6 | −75.7 ± 0.4 | −40.9 ± 0.1 | 78.3 ± 0.4 | −6.0 ± 0.0 | −30.4 ± 0.1 | −13.8 ± 0.2 |
DB12329 | −8.8 | −45.7 ± 0.4 | −25.5 ± 0.6 | 45.0 ± 0.3 | −3.4 ± 0.0 | −21.8 ± 0.0 | −7.7 ± 0.5 |
DB00385 | −9.2 | −59.8 ± 0.2 | −21.5 ± 0.2 | 52.8 ± 0.4 | −4.6 ± 0.0 | −25.9 ± 0.1 | −7.2 ± 0.1 |
DB01601 (Lopinavir) | −9.8 | −52.5 ± 0.3 | −20.1 ± 0.6 | 46.6 ± 0.6 | −4.6 ± 0.0 | −23.9 ± 0.0 | −6.6 ± 0.3 |
DB11574 | −9.9 | −70.6 ± 0.4 | −21.8 ± 0.4 | 65.6 ± 0.6 | −6.4 ± 0.0 | −26.6 ± 0.2 | −6.5 ± 0.3 |
Charged Approved Drugs | |||||||
DB01082 (NC=0) | −8.6 | −46.0 ± 0.4 | −71.7 ± 1.0 | 89.4 ± 0.9 | −3.8 ± 0.0 | −24.2 ± 0.0 | −7.9 ± 0.4 |
DB01082 (NC=2) | −6.9 | −33.4 ± 0.6 | −280.0 ± 1.6 | 291.7± 1.3 | −3.4 ± 0.0 | −21.2 ± 0.1 | −3.8 ± 0.5 |
DB03147 (NC=0) | −10.2 | −67.8 ± 0.3 | −67.6 ± 0.9 | 106.6 ± 0.6 | −5.0 ± 0.0 | −26.3 ± 0.1 | −7.5 ± 0.5 |
DB03147 (NC=−2) | −8.3 | −52.9 ± 0.1 | 123.0 ± 0.3 | −74.3 ± 0.5 | −4.5 ± 0.0 | −23.2 ± 0.1 | 14.6 ± 0.3 |
DB11184 (NC=0) | −8.6 | −57.4 ± 0.8 | −52.2 ± 0.4 | 82.2 ± 0.3 | −4.9 ± 0.0 | −25.4 ± 0.1 | −6.8 ± 0.3 |
DB11184 (NC=−4) | −7.4 | −50.1 ± 0.4 | 175.4 ± 1.6 | −148.7 ± 0.8 | −4.4 ± 0.0 | −22.9 ± 0.1 | −5.0 ± 0.5 |
Bio-actives Structurally Similar to Lopinavir | |||||||
23727975 | −8.8 | −63.8 ± 0.1 | −50.1 ± 0.7 | 77.91± 0.1 | −5.2 ± 0.0 | −28.3 ± 0.1 | −12.9 ± 0.5 |
88143175 (NC = 0) | −10.0 | −73.9 ± 0.2 | −104.5 ± 1.3 | 148.9 ± 0.9 | −6.6 ± 0.0 | −30.5 ± 0.0 | −5.6 ± 0.6 |